Discontinued — last reported Q4 '25
Operating Cash Flow
OperatingEli Lilly Operating Cash Flow decreased by 63.5% to $3.22B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 30.4%, from $2.47B to $3.22B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 23.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher values indicate a self-sustaining business with strong cash generation; a significant divergence from net income can signal high-quality earnings or potential accounting red flags.
Detailed definition
The total amount of cash generated by a company's core business operations, calculated by adjusting net income for non-c...
Peer comparison
This is the gold standard for comparing the cash-generating power of tech giants like Amazon, Google, and Microsoft.
cf_net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.78B | $1.63B | $2.16B | $2.50B | $820.70M | $2.18B | $1.58B | $1.73B | $631.90M | $2.19B | $0.00 | $1.17B | $1.47B | $3.71B | $2.47B | $1.67B | $3.09B | $8.84B | $3.22B |
| QoQ Change | — | -8.1% | +32.2% | +15.9% | -67.2% | +166.2% | -27.7% | +9.6% | -63.5% | +246.5% | -100.0% | — | +25.7% | +153.2% | -33.4% | -32.7% | +85.3% | +186.2% | -63.5% |
| YoY Change | — | — | — | — | -53.8% | +33.9% | -26.7% | -30.8% | -23.0% | +0.2% | -100.0% | -32.6% | +132.0% | +69.5% | — | +42.8% | +110.5% | +138.0% | +30.4% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Eli Lilly's operating cash flow?
- Eli Lilly (LLY) reported operating cash flow of $3.22B in Q4 2025.
- How has Eli Lilly's operating cash flow changed year-over-year?
- Eli Lilly's operating cash flow increased by 30.4% year-over-year, from $2.47B to $3.22B.
- What is the long-term trend for Eli Lilly's operating cash flow?
- Over 4 years (2021 to 2025), Eli Lilly's operating cash flow has grown at a 23.4% compound annual growth rate (CAGR), from $7.26B to $16.81B.
- What does operating cash flow mean?
- The actual cash a company brings in from its day-to-day business activities.